Almirall LLC
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$10.3M
Doctors Paid
9,438
Transactions
45,341
2024 Total
$945,338
Payment Breakdown by Category
Research$5.6M (54.3%)
Consulting$1.9M (18.6%)
Food & Beverage$966,932 (9.4%)
Travel$239,983 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $5.6M | 581 | 54.3% |
| Consulting Fee | $1.9M | 753 | 18.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.4M | 677 | 14.0% |
| Food and Beverage | $966,932 | 42,581 | 9.4% |
| Travel and Lodging | $239,983 | 578 | 2.3% |
| Grant | $108,840 | 1 | 1.1% |
| Honoraria | $24,100 | 10 | 0.2% |
| Education | $1,883 | 160 | 0.0% |
Payments by Type
Research
$5.6M
581 transactions
General
$4.7M
44,760 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| M14867-32 | $1.3M | 2 | 201 |
| Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES) | $537,956 | 32 | 147 |
| KLISYRI-IIS US Biomarkers Seykora | $435,617 | 1 | 3 |
| H2200518 - SEYSARA-IIS Dr. Bunick MOA Study | $330,607 | 0 | 2 |
| THE USE OF Sarecycline IN THE TREATMENT OF ROSACEA | $322,373 | 0 | 2 |
| SEYSARA IN THE TREATMENT OF ROSACEA | $322,373 | 0 | 1 |
| Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis (PROAK) | $265,401 | 4 | 58 |
| Elucidating Novel Therapeutic Targets in Hidradenitis Suppurativa | $247,569 | 0 | 4 |
| Mode of action of sarecycline on the bacterial ribosome | $236,984 | 0 | 2 |
| PROAK | $223,535 | 1 | 33 |
| M-27134-01 | $209,035 | 0 | 89 |
| IIS Dr Kircik Patient preference comparing two CAL/BPD fixed dose combinations | $122,000 | 1 | 3 |
| Sarecycline Truncal Acne Safety and Efficacy Response (TASER) Study | $105,000 | 0 | 2 |
| A patient preference study comparing two CAL/BDP fixed dose combinations used for the topical treatment of plaque psoriasis, one formulated as a cream Wynzora and the other as a foam Enstila | $100,000 | 0 | 2 |
| H2200555 KLISYRI-IIS US Tirba SCCIS Lain | $56,058 | 0 | 1 |
| ACZONE GEL IN THE TREATMENT OF ACNE VULGARIS | $52,004 | 0 | 5 |
| PhIV-IIS - RWE Tirbanibulin NMSC | $50,000 | 0 | 2 |
| Klisyri - IIS Dr. Feldman - Investigator-initiated Study of Field of Cancerization Size | $50,000 | 0 | 2 |
| Klisyri - IIS Dr. Feldman - Investigator-initiated Study of Patient Refusal FU | $41,029 | 0 | 2 |
| ROLE OF ANTIBIOTICS IN THE TREATMENT OF ACNE VULGARIS | $40,000 | 0 | 2 |
| IIS Dr. Lain - Tirbanibulin for sBCC – US | $37,373 | 0 | 1 |
| An open-label study to investigate the efficacy and tolerability of Aczone gel, 7.5% in the treatment of acne vulgaris in men and women with Fitzpatrick skin types IV-VI | $35,478 | 0 | 1 |
| Systematic Review of safety, tolerability and patient-reported outcomes of topical treatments in actinic keratosis | $30,000 | 0 | 2 |
| Klisyri - IIS Dr. Feldman - Investigator-initiated Study of Call Backs | $30,000 | 0 | 1 |
| PhIV-IIS - RWE Tirbanibulin for Condyloma Angela Yen Moore | $28,500 | 0 | 2 |
| Research | $20,000 | 0 | 1 |
| A Single-Center Pilot Study to Evaluate the Efficacy, Safety, and Tolerability of Sarecycline for Treating Periorificial Dermatitis | $20,000 | 1 | 1 |
| Perioral Dermatitis IIS | $17,610 | 1 | 2 |
| AD Survey testing | $2,400 | 1 | 2 |
Payments by Medical Specialty
Top Paid Doctors — Page 4
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Christopher Obeime, Md, MD | Specialist | Indianapolis, IN | $12,131 | $0 |
| Dr. Jonathan Silverberg, Md, Phd, Mph, MD, PHD, MPH | Dermatology | Washington, DC | $12,090 | $0 |
| Dr. Richard Fried, M.d.,Ph.d, M.D.,PH.D | Dermatology | Yardley, PA | $11,784 | $0 |
| Dr. Adam Friedman, M.d, M.D | Dermatology | Washington, DC | $11,645 | $0 |
| Dr. Nathan Weir, M.d., Ph.d, M.D., PH.D | Dermatology | Mason, OH | $11,412 | $0 |
| Dr. Amy Spizuoco, D.o, D.O | Dermatology | New York, NY | $11,368 | $0 |
| Dr. Jerald Sklar, M. D, M. D | Dermatology | Dallas, TX | $11,335 | $0 |
| Dr. Eric Baum, M.d, M.D | Specialist | Gadsden, AL | $11,137 | $0 |
| Dr. Aaron Farberg, M.d, M.D | MOHS-Micrographic Surgery | Rockwall, TX | $11,020 | $0 |
| Dr. Christy Rainey, M.d, M.D | Dermatology | Branson, MO | $11,020 | $0 |
| Alan Fleischer, Md, MD | Dermatology | Cincinnati, OH | $11,000 | $0 |
| Dr. Dhaval Bhanusali, M.d, M.D | Dermatology | New York, NY | $10,972 | $0 |
| Mr. Corey Hartman, M.d, M.D | Dermatology | Birmingham, AL | $10,901 | $0 |
| Dr. Katherine Holcomb, M.d, M.D | Dermatology | Metairie, LA | $10,351 | $0 |
| Stephen Tyring, Md Phd, MD PHD | Dermatology | Webster, TX | $9,969 | $0 |
| John Harris, Md, MD | Dermatology | Worcester, MA | $9,796 | $0 |
| Mrs. Debra Grayman, M.d, M.D | Dermatology | Orlando, FL | $9,720 | $0 |
| Roger Ceilley, M.d, M.D | MOHS-Micrographic Surgery | West Des Moines, IA | $9,677 | $0 |
| Dr. Valerie Callender, M.d, M.D | Dermatology | Glenn Dale, MD | $9,631 | $0 |
| Dr. Brian Kim, Md, MD | Dermatology | Saint Louis, MO | $9,625 | $0 |
| Mark Nestor, M.d, M.D | Dermatology | Aventura, FL | $9,606 | $0 |
| Alexander Dane, D.o, D.O | Dermatology | Largo, FL | $9,441 | $0 |
| Omar Noor, M.d, M.D | Student in an Organized Health Care Education/Training Program | Somerset, NJ | $8,947 | $0 |
| Kenneth Washenik, M.d, M.D | Dermatology | Beverly Hills, CA | $8,877 | $0 |
| Andrew Dorizas, M.d, M.D | MOHS-Micrographic Surgery | West Palm Beach, FL | $8,723 | $0 |
About Almirall LLC
Almirall LLC has made $10.3M in payments to 9,438 healthcare providers, recorded across 45,341 transactions in the CMS Open Payments database. In 2024, the company paid $945,338. The top product by payment volume is Klisyri ($2.1M).
Payments were distributed across 111 medical specialties. The top specialty by payment amount is Dermatology ($4.1M to 4,066 doctors).
Payment categories include: Food & Beverage ($966,932), Consulting ($1.9M), Research ($5.6M), Travel & Lodging ($239,983).
Almirall LLC is associated with 6 products in the CMS Open Payments database, including Klisyri, Seysara, and SEYSARA.